New drug cocktails aim to knock out stomach bug
NCT ID NCT06349486
First seen Jan 17, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study compares three different 14-day treatments for H. pylori, a bacteria that can cause stomach ulcers. About 390 infected adults will receive either a new triple therapy with bismuth, amoxicillin, and vonoprazan; a dual therapy with vonoprazan and amoxicillin; or a standard triple therapy. The goal is to see which treatment works best and is safest, while also looking at how antibiotic resistance and genetics affect success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI ERADICATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kaohsiung Medical University Hospital
RECRUITINGKaohsiung City, 807, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.